Larry Robbins's NVS Position Overview
Larry Robbins (via Glenview Capital Management, LLC) currently holds 86,909 shares of Novartis AG (NVS) worth $13.62 M, representing 0.25% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Larry Robbins has initiated a new position in NVS, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Larry Robbins's Novartis (NVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novartis (NVS) Trades by Larry Robbins
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +86,909 | New Buy | 86,909 | $156.72 |
Larry Robbins's Novartis Investment FAQs
Larry Robbins first purchased Novartis AG (NVS) in Q2 2026, acquiring 86,909 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins has held Novartis AG (NVS) for 1 quarters since Q2 2026.
Larry Robbins's largest addition to Novartis AG (NVS) was in Q2 2026, adding 86,909 shares worth $13.62 M.
According to the latest 13F filing for Q2 2026, Larry Robbins's firm, Glenview Capital Management, LLC, owns 86,909 shares of Novartis AG (NVS), valued at approximately $13.62 M.
As of the Q2 2026 filing, Novartis AG (NVS) represents approximately 0.25% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.
Larry Robbins's peak holding in Novartis AG (NVS) was 86,909 shares, as reported at the end of Q2 2026.